Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 82

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 82
---
 |     |        |        |     |              |        |     |        |        |     |              |        |     |        |        |     |        |            |     |        |        |     |             |        |     |        |        |     |            |            |   |     |               |          |   |     |             | (534,739    | ) |     |       |   (534,739 | ) |
| Balance                              
 March 31, 2025                       |     |             | 10,123,771 |     | $      |  1,011 |     |              |     34 |     |        | -      |     |              | 15,007 |     | $      |      2 |     |        | 21,554,704 |     | $      |  2,157 |     |             | 29,338 |     | $      |      3 |     | $          | 15,455,134 |   |     | $             | (204,847 | ) |     | $           | (20,951,859 | ) |     | $     | (5,698,399 | ) |
| Balance                              |     |             | 10,123,771 |     | $      |  1,011 |     |              |     34 |     |        | -      |     |              | 15,007 |     | $      |      2 |     |        | 21,554,704 |     | $      |  2,157 |     |             | 29,338 |     | $      |      3 |     | $          | 15,455,134 |   |     | $             | (204,847 | ) |     | $           | (20,951,859 | ) |     | $     | (5,698,399 | ) |

The Accompanying Notes are an Integral Part of These Financial Statements

All stock amounts have been retroactively adjusted to reflect a 1 for 1500 reverse stock split of all issued series of stock effective as of March 6, 2023

| 68 |

REGEN BIOPHARMA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

|                                                                         |     | Six          
 Months Ended 
 March        
 31, 2025     |          |